Cargando…

Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis

Serum α-fetoprotein- (AFP-) elevated gastric cancer is a rare tumor that has a poor prognosis due to high incidence of liver metastasis. This study sought to investigate the optimal treatment modality. A total of 319 gastric cancer patients with liver metastasis (GCLM) whose serum AFP levels were te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yakun, Shen, Lin, Lu, Ming, Ji, Zhi, Zhang, Xiaotian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757133/ https://www.ncbi.nlm.nih.gov/pubmed/29434637 http://dx.doi.org/10.1155/2017/5080361

Ejemplares similares

Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma
por: Thumaty, Divya Bala, et al.
Publicado: (2021)

Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases
por: Miyazaki, Tatsuya, et al.
Publicado: (2018)

Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma
por: Wang, Bingzhi, et al.
Publicado: (2021)

Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP
por: Wang, Ya-Kun, et al.
Publicado: (2018)

Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020)

Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis
por: Chen, Yonghe, et al.
Publicado: (2021)

Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancer
por: Li, Zhu, et al.
Publicado: (2017)

Relationship between the Expression of the Thymidylate Synthase and the Prognosis of Gastric Cancer Patients Treated with Combinational Chemotherapy Regimen Including Fluorouracil, Docetaxel and Cisplatin
por: Aznab, Mozaffar, et al.
Publicado: (2020)

Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Activated Wnt signaling promotes growth and progression of AFP-producing gastric cancer in preclinical models
por: Chen, Dongshao, et al.
Publicado: (2019)

Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases
por: Wang, Ting, et al.
Publicado: (2017)

AFP
Publicado: (2009)

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer
por: Loupakis, Fotios, et al.
Publicado: (2015)

Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study
por: Wang, Lei, et al.
Publicado: (2023)

Status of AFP
por: Erland, Paula Agnieszka
Publicado: (2019)

The AFP Project
por: Staszewski, R.
Publicado: (2011)

Expression of AFP and STAT3 Is Involved in Arsenic Trioxide-Induced Apoptosis and Inhibition of Proliferation in AFP-Producing Gastric Cancer Cells
por: Jia, Yanfei, et al.
Publicado: (2013)

Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer
por: Sun, Wenhui, et al.
Publicado: (2017)

Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer
por: Li, Ningning, et al.
Publicado: (2020)

XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)
por: Zhu, Xiao‐Dong, et al.
Publicado: (2022)

Effect of multimodal chemotherapy on survival of gastric cancer with liver metastasis – a population based analysis
por: Li, Xinghui, et al.
Publicado: (2023)

Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study
por: Zhang, Lingyun, et al.
Publicado: (2022)

A pilot phase II study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer
por: Zhou, Haitao, et al.
Publicado: (2016)

Multimodal Treatment Including Intracavitary Chemotherapy for Recurrent Pediatric Pleuropulmonary Blastoma
por: Habti, Merieme, et al.
Publicado: (2021)

Investigation of Potential Molecular Biomarkers for Diagnosis and Prognosis of AFP-Negative HCC
por: Liu, Zijing, et al.
Publicado: (2021)

A case of a long-term survival achieved by surgical treatment and chemotherapy for late recurrence of AFP-producing gastric cancer
por: Harada, Manabu, et al.
Publicado: (2019)

Effective treatment of apatinib for chemotherapy-refractory advanced gastric carcinoma with AFP-secretion and HER2-positivity: A case report
por: Ding, Xinjing, et al.
Publicado: (2021)

DCS and TDAQ for AFP
por: Banas, Elzbieta, et al.
Publicado: (2017)

AFP Project in ATLAS
por: Tasevsky, M
Publicado: (2017)

First AFP results
por: Staszewski, Rafal
Publicado: (2017)

Overview of AFP performance
por: Liu, Jesse Kar Kee
Publicado: (2021)

The ATLAS AFP Spectrometer
por: Newman, Paul Richard
Publicado: (2021)

Overview of AFP Detector
por: Auriol, Adrien
Publicado: (2023)

CT characteristics for predicting prognosis of gastric cancer with synchronous peritoneal metastasis
por: Li, Jiazheng, et al.
Publicado: (2023)

LARP1 predict the prognosis for early-stage and AFP-normal hepatocellular carcinoma
por: Xie, Chan, et al.
Publicado: (2013)

α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
por: Mao, Xiang, et al.
Publicado: (2023)

Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray
por: Wu, Min, et al.
Publicado: (2018)

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022)

Status of the AFP Project in ATLAS
por: Tasevsky, Marek
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9h7ijakgaesb345qjde2s8tjfb